Exploratory Analyses in Advanced Melanoma and NSCLC Presented in Oral Session
Dr. Roger Perlmutter to Present at AACR Opening Plenary Session
Early Findings Exploring the Relationship of PD-L1 Expression and Clinical Outcomes with MK-3475, Merck’s Investigational Anti-PD-1 Immunotherapy, Presented at AACR Annual Meeting 2014 | Merck Newsroom Home
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.